Note: Ingredients listed on restricted chemical lists
EC/CAS
872-50-4
Name of the chemical
N-Methyl-2-Pyrrolidone; 1-methyl-2-pyrrolidone (NMP)
Concentration
N/A
General Information
Revision date
2011-11-03
Product name
Plumma’s Large Diameter PVC Solvent Cement
1.2.1 Relevant identified uses
For Joining Non-Pressure PVC-U Pipes and Fittings
Emergency telephone
Poisons Information Centre
Icons in SDS
Company Information
company name
Atherton Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
admin@athertonchemicals.com.au
Section 2
SECTION 2: Hazards identification
HAZARDOUS ACCORDING TO THE CRITERIA OF WORKSAFE AUSTRALIA Classified as Dangerous Goods according to Australian Dangerous Goods (ADG) Code.
Hazard statements
R11, R20, R36, R37, R66 and R67. Highly flammable. Irritating to eyes and respiratory system. Harmful by inhalation. Repeated exposure may cause skin dryness or cracking. Vapours may cause drowsiness and dizziness.
Precautionary statements
S2, S9, S16, S29, and S33. Keep out of the reach of children. Keep container in a well ventilated place. Keep away from sources of ignition – NO SMOKING. Do not empty into drains. Take against static discharge
Health hazards
Vapours may cause drowsiness and dizziness. This product may cause moderate irritation to the skin. Repeated exposure may cause skin dryness or cracking. The product is irritating to the eyes. HARMFUL: may cause damage if swallowed. Signs and Symptoms: Eye irritation signs and symptoms may include a burning sensation, redness, swelling and/or blurred vision. Defatting dermatitis signs and symptoms may include a burning sensation and/or a dried/cracked skin appearance. Respiratory irritation signs and symptoms may include a temporary burning sensation of the nose and throat, coughing and/or difficulty breathing. If material enters the lungs, signs and symptoms may include coughing, choking, wheezing, difficulty breathing, chest congestion, shortness of breath, and/or fever. Breathing of high vapour concentrations may cause central nervous system (CNS) depression resulting in dizziness, light-headedness, headache, nausea and loss of coordination. Continued inhalation may result in unconsciousness and death.
Medical Conditions Generally Aggravated by Exposure
Pre-existing medical conditions of the following organ(s) or organ system(s) may be aggravated by exposure to this product: Eyes; Respiratory system; Skin. 3. Composition/Information regarding Ingredients Ingredients CAS No. Conc., % TWA (mg/m³) STEL (mg/m³) Methyl Ethyl Ketone 78-93-3 20-40 150 300 Cyclohexanone 108-94-1 20 - 40 200 N-Methyl 2 Pyrrolidone 872-50-4 1 – 5 not listed Gamma Butyrolactone 96-48-0 5 - 20 not listed Other ingredients which are classified as non-hazardous, to 100%. Note: This is a commercial product whose exact ratio of ingredients may vary slightly. Minor quantities of other non hazardous ingredients are also possible.